An Engineered Allogeneic Artificial Antigen-Presenting Red Cell Therapeutic™, RTX-321, Promotes Antigen-Specific T Cell Expansion and Anti-Tumor Activity

Xuqing Zhang, Mengyao Luo, Shamael R Dastagir, Mellissa Nixon, Annie Khamhoung, Andrea Schmidt, Billy Blanco, Viral Amin, Ryan Pepi, Timothy J Lyford, Laurence A Turka, Thomas J Wickham, and Tiffany F Chen

FOCIS 2020 RTX-321 Audio Recording